Mendel.ai
Billy Deitch is the Director at Mendel.ai. Billy has also served as an Investor at OODA Health, a Member of the Board of Directors at Dynamo Software and CONNECTURE, and as an Observer on the Board of Directors at Source Photonics. Prior to their current role, Deitch was a Partner at Francisco Partners and held various positions at Brightline, Everside Health, Oak HC/FT, and Olive.
Billy Deitch completed their undergraduate degree at Yale University in Billy'story and then went on to obtain their Master of Business Administration at the Stanford Graduate School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Mendel.ai
2 followers
Mendel.ai's mission is to use their novel AI aided by clinical experts to streamline global oncology research by organizing real-world data and automating clinical trials. Mendel.ai builds software to solve problems at each stage of the clinical trial process, from feasibility to post-trial pharmacovigilance.